CCDRD Cooperative Clinical Drug Research and Development AG

• Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl Pending
  2024-517506-29-00 1 country
• Treatment of adenomyosis in women of reproductive age. Pending
  2025-523076-23-00 Phase II 1 country IBUPROFEN; SODIUM CHLORIDE; SODIUM VALPROATE
• Bioavailability study with naloxone hydrochloride in healthy volunteers Ended
  2024-517838-17-00 1 country
• Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 60… Ended
  2025-520572-25-00 1 country
• A phase 1, double-blind, placebo-controlled, randomized, single ascending dose and multiple ascending dose study to assess the safety, toler… Ended
  2024-519813-74-00 Phase I (Other) 1 country
• Evaluation of the bioequivalence of two products containing esomeprazole under fasting conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. … Ended
  2024-512401-89-00 1 country
• Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl Ended
  2023-504698-19-00 1 country
• Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTE… Ended
  2024-517969-16-00 Phase I (Other) 1 country
• Evaluation of the bioequivalence of two products containing esomeprazole under fed conditions: Esomeprazole-Syrup 40 mg dose (Test) vs. Nexi… Ended
  2024-512674-97-00 1 country
• A study to compare two different aramchol formulations in healthy volunteers. Ended
  2023-507445-28-00 Phase I (Other) 1 country
• Evaluation of bioequivalence of two products containing 50 mg dimenhydrinate: Dimenhydrinate 50 mg (Test) vs. Vomex A 50 mg Lösung zum Einne… Ended
  2024-515170-27-00 1 country
• Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated gr… Ended
  2023-509752-34-00 1 country
• Conducting a quality study of the medicinal product - Vortioxetine Ended
  2023-509946-36-00 1 country
• Multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management. Ended
  2024-519625-38-00 Phase III 2 countries FENTANYL CITRATE; MORPHINE SULFATE PENTAHYDRATE; PLACEBO
• Evaluation of the bioavailability of two products containing esomeprazole under fasting and fed conditions: Esomeprazole-Syrup 40 mg dose (T… Ended
  2023-506701-18-00 Phase I (Other) 1 country
• Bioequivalence of Cladribine 10 mg from two different products Ended
  2023-508656-19-00 1 country
• A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered sub… Ended
  2023-508013-16-00 Phase III 2 countries BETULA PENDULA POLLEN ALLERGOID, MANNAN-CONJUGATED, POLYMERISED
• An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavaila… Ended
  2022-502420-51-00 1 country
• A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R… Ended
  2023-504687-42-00 Phase I (Other) 1 country LEVODOPA
• A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended
  2023-509025-41-00 1 country
• A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended
  2024-515876-10-00 1 country
• Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended
  2025-522252-74-00 1 country

Showing 1–22 of 22 trials